Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine

Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Dandan Li, Hongbo Chen, Runxiang Long, Zhimei Zhao, Tangwei Mou, Heng Zhao, Shiyin Feng, Zhongping Xie, Lichun Wang, Zhanlong He, Yun Liao, Shengtao Fan, Qiongzhou Yin, Ruiju Jiang, Jianfeng Wang, Lingli Zhang, Jing Li, Huiwen Zheng, Pingfang Cui, Guorun Jiang, Lei Guo, Mingjue Xu, Huijuan Yang, Shan Lu, Xuanyi Wang, Yang Gao, Xingli Xu, Linrui Cai, Jian Zhou, Li Yu, Zhuo Chen, Chao Hong, Dan Du, Hongling Zhao, Yan Li, Kaili Ma, Yunfei Ma, Donglan Liu, Shibao Yao, Changgui Li, Yanchun Che, Longding Liu, Qihan Li
doi: https://doi.org/10.1101/2020.09.27.20189548
Jing Pu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qin Yu
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhifang Yin
3National Institute of Food and Drug Control, Beijing, 100050, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Zhang
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xueqi Li
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dandan Li
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongbo Chen
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Runxiang Long
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhimei Zhao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tangwei Mou
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heng Zhao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiyin Feng
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhongping Xie
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lichun Wang
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhanlong He
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun Liao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shengtao Fan
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiongzhou Yin
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruiju Jiang
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianfeng Wang
3National Institute of Food and Drug Control, Beijing, 100050, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lingli Zhang
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Li
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huiwen Zheng
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pingfang Cui
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guorun Jiang
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Guo
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingjue Xu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huijuan Yang
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shan Lu
4Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuanyi Wang
5The Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Gao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xingli Xu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linrui Cai
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Zhou
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Yu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhuo Chen
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chao Hong
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Du
2National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongling Zhao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Li
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaili Ma
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunfei Ma
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donglan Liu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shibao Yao
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changgui Li
3National Institute of Food and Drug Control, Beijing, 100050, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liqihan@imbcams.com.cn liuld@imbcams.com.cn cheyanchun@imbcams.com.cn changguili@aliyun.com
Yanchun Che
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liqihan@imbcams.com.cn liuld@imbcams.com.cn cheyanchun@imbcams.com.cn changguili@aliyun.com
Longding Liu
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liqihan@imbcams.com.cn liuld@imbcams.com.cn cheyanchun@imbcams.com.cn changguili@aliyun.com
Qihan Li
1Institute of Medical Biology, Chinese Academy of Medicine Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, 650118, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liqihan@imbcams.com.cn liuld@imbcams.com.cn cheyanchun@imbcams.com.cn changguili@aliyun.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND In-depth investigations of the safety and immunogenicity of inactivated SARS-CoV-2 vaccines are needed.

METHOD In a phase I randomized, double-blinded, and placebo-controlled trial involving 192 healthy adults 18-59 years of age, two injections of three different doses (50 EU, 100 EU and 150 EU) of an inactivated SARS-CoV-2 vaccine or the placebo were administered intramuscularly with a 2- or 4-week interval between the injections. The safety and immunogenicity of the vaccine were evaluated within 28 days.

FINDING In this study, 191 subjects assigned to three doses groups or the placebo group completed the 28-day trial. There were 44 adverse reactions within the 28 days, most commonly mild pain and redness at the injection site or slight fatigue, and no abnormal variations were observed in 48 cytokines in the serum samples of immunized subjects. The serum samples diluted from 1:32 to 1:4096 and incubated with the virus did not show antibody-dependent enhancement effects (ADEs) with regard to human natural killer cells, macrophages or dendritic cells. At day 14, the seroconversion rates had reached 92%, 100% and 96% with geometric mean titers (GMTs) of 18.0, 54.5 and 37.1, and at day 28, the seroconversion rates had reached 80%, 96% and 92% with GMTs of 10.6, 15.4 and 19.6in 0, 14 and 0, 28 procedures, respectively. Seroconversion was associated with the synchronous upregulation of ELISA antibodies against the S protein, N protein and virion and a cytotoxic T lymphocyte (CTL) response. Transcriptome analysis shaped the genetic diversity of immune response induced by the vaccine.

INTERPRETATION In a population aged 18-59 years, this inactivated SARS-CoV-2 vaccine was safe and immunogenic.

Trial registration NCT04412538

FUNDING The National Key R&D Program of China (2020YFC0849700), the Program of Chinese Academy of Medicine Science and the Major Science and Technology Special Projects of Yunnan Province.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04412538

Funding Statement

This work was supported by National Key R&D Program of China (2020YFC0849700), the Program of Chinese Academy of Medicine Science and the Major science and technology special projects of Yunnan Province.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was reviewed and approved by the Ethics Committee of the West China Second University Hospital, Sichuan University.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵# Co-first authors: Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Dandan Li and Hongbo Chen contributed equally to this study.

Data Availability

All data were available.The raw microarray data were submitted to the National Genomics Data Center (NGDC) and are available (PRJCA003531).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Dandan Li, Hongbo Chen, Runxiang Long, Zhimei Zhao, Tangwei Mou, Heng Zhao, Shiyin Feng, Zhongping Xie, Lichun Wang, Zhanlong He, Yun Liao, Shengtao Fan, Qiongzhou Yin, Ruiju Jiang, Jianfeng Wang, Lingli Zhang, Jing Li, Huiwen Zheng, Pingfang Cui, Guorun Jiang, Lei Guo, Mingjue Xu, Huijuan Yang, Shan Lu, Xuanyi Wang, Yang Gao, Xingli Xu, Linrui Cai, Jian Zhou, Li Yu, Zhuo Chen, Chao Hong, Dan Du, Hongling Zhao, Yan Li, Kaili Ma, Yunfei Ma, Donglan Liu, Shibao Yao, Changgui Li, Yanchun Che, Longding Liu, Qihan Li
medRxiv 2020.09.27.20189548; doi: https://doi.org/10.1101/2020.09.27.20189548
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Dandan Li, Hongbo Chen, Runxiang Long, Zhimei Zhao, Tangwei Mou, Heng Zhao, Shiyin Feng, Zhongping Xie, Lichun Wang, Zhanlong He, Yun Liao, Shengtao Fan, Qiongzhou Yin, Ruiju Jiang, Jianfeng Wang, Lingli Zhang, Jing Li, Huiwen Zheng, Pingfang Cui, Guorun Jiang, Lei Guo, Mingjue Xu, Huijuan Yang, Shan Lu, Xuanyi Wang, Yang Gao, Xingli Xu, Linrui Cai, Jian Zhou, Li Yu, Zhuo Chen, Chao Hong, Dan Du, Hongling Zhao, Yan Li, Kaili Ma, Yunfei Ma, Donglan Liu, Shibao Yao, Changgui Li, Yanchun Che, Longding Liu, Qihan Li
medRxiv 2020.09.27.20189548; doi: https://doi.org/10.1101/2020.09.27.20189548

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (47)
  • Cardiovascular Medicine (416)
  • Dentistry and Oral Medicine (70)
  • Dermatology (49)
  • Emergency Medicine (146)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4875)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (678)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (633)
  • Health Policy (322)
  • Health Systems and Quality Improvement (208)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5361)
  • Intensive Care and Critical Care Medicine (332)
  • Medical Education (94)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (690)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (127)
  • Occupational and Environmental Health (209)
  • Oncology (443)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (17)
  • Pathology (130)
  • Pediatrics (196)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (782)
  • Public and Global Health (1823)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)